Search

Advanced Gastrointestinal (GI) Disorder Animal Model Service for Probiotic Efficacy Evaluation

In the rapidly expanding field of gut health and the microbiome, understanding the precise efficacy of probiotic strains in complex GI disorders is paramount. Creative Biolabs specializes in providing cutting-edge Advanced Gastrointestinal (GI) Disorder Animal Model services designed to thoroughly evaluate the therapeutic potential of your probiotic products. We offer a comprehensive suite of research solutions, from initial mechanistic studies to robust efficacy evaluations, helping you accelerate your product development and bring innovative solutions to market faster. Request a quote

Fig.1 GI disorder animal models for probiotic efficacy evaluation. (Creative Biolabs Authorized)

Service Overview: Bridging the Gap Between Discovery and Clinical Success

Here are dedicated to showcasing our expertise in assessing probiotic efficacy within physiologically relevant animal models of advanced GI disorders. We understand the intricate interplay between the gut microbiota, host immunity, and disease pathology. Our tailored studies provide in-depth insights into how your probiotic interventions can modulate these interactions, leading to tangible health benefits. We aim to be your trusted partner in navigating the complexities of preclinical probiotic research.

Your Comprehensive Research Partner: GI Disorder Animal Model Services for Probiotic Efficacy Evaluation

Our full-spectrum services cover every stage of engineered probiotic development:

Workflow

Fig.2 The workflow for the probiotic efficacy evaluation in GI disorder animal models. (Creative Biolabs original)

Service Details

Animal Models
Administration
Analysis
Samples
Deliverables
Turnaround Time

Animal Models

  • Inflammatory Bowel Disease (IBD) Models
    • DSS-induced colitis: A widely used model for acute and chronic colitis, allowing assessment of inflammation, weight loss, disease activity index (DAI), and histological changes. We can customize protocols (e.g., antibiotic pre-treatment, germ-free settings) to explore specific microbiome interactions.
    • TNBS-induced colitis: Mimics features of Crohn's disease, involving T-cell-mediated inflammation.
    • IL-10 knockout mice: A genetic model for spontaneous chronic colitis.
  • Irritable Bowel Syndrome (IBS) Models
    • Stress-induced IBS models: To evaluate visceral hypersensitivity and altered gut motility.
    • Post-infectious IBS models: Mimicking the development of IBS following gastrointestinal infections.

Probiotic Administration

  • Oral Gavage: Standardized administration of probiotic formulations.
  • Dietary Inclusion: Incorporating probiotics directly into animal feed.
  • Long-term and Acute Dosing Regimens: Tailored to mimic various human consumption patterns.
  • Dose-Response Studies: To determine optimal therapeutic concentrations.

Comprehensive Endpoint Analysis

  • Clinical Observations: Body weight, food and water intake, disease activity index (DAI), and stool consistency.
  • Histopathology: Detailed microscopic evaluation of GI tissues for inflammation, damage, crypt architecture, goblet cell numbers, etc. (e.g., H&E, PAS staining).
  • Immunological Biomarkers
    • Cytokine and Chemokine Profiling: ELISA, multiplex assays, or qPCR to measure pro-inflammatory (e.g., TNF-α, IL-6) and anti-inflammatory (e.g., IL-10, TGF-β) mediators in serum, tissue homogenates, and fecal samples.
    • Flow Cytometry: Immunophenotyping of immune cells (T cells, B cells, macrophages, dendritic cells) from Peyer's patches, mesenteric lymph nodes, and lamina propria.
    • Myeloperoxidase (MPO) Activity: A marker of neutrophil infiltration and inflammation.
  • Microbiome Analysis
  • Intestinal Barrier Function Assessment
    • FITC-Dextran Permeability Assay: Measurement of intestinal permeability (leaky gut).
    • Transepithelial Electrical Resistance (TEER) in ex vivo Ussing Chamber studies.
    • Expression of tight junction proteins (e.g., ZO-1, Occludin, Claudins) by Western blot or immunohistochemistry.
  • Mucin Layer Integrity: Quantification of mucin production and thickness.
  • Metabolic Markers: Glucose, insulin, lipid profiles in serum.
  • Gene Expression Analysis: qPCR for target genes related to inflammation, metabolism, and barrier function in GI tissues.
  • Targeted Metabolomics: Analysis of specific metabolites influenced by probiotic intervention (e.g., bile acids).

Sample Information

  • Client-Provided Probiotics: We require detailed information on your probiotic strains, including species, strain identifier, viability (CFU/g or CFU/mL), storage conditions, and safety data.
  • Sample Delivery: Probiotic samples should be shipped according to agreed-upon instructions, ensuring viability upon arrival.

Deliverables

  • Comprehensive written report with detailed methodology, results, statistical analysis, and interpretation.
  • High-resolution graphs and tables summarizing key findings.
  • Raw data files from all analyses (e.g., sequencing data, raw absorbance values, histological images).

Turnaround Time

Project timelines vary depending on the complexity of the study design, animal model, and number of endpoints. We will provide a detailed timeline with your customized proposal, typically ranging from 8 to 16 weeks from study initiation to final report delivery. Expedited options may be available upon request.

Contact Us Today for a Quote

Advantages of Partnering with Creative Biolabs

Expertise in GI Physiology & Microbiome Research

Our team comprises highly skilled scientists with extensive experience in gastroenterology, microbiology, immunology, and preclinical animal models.

State-of-the-Art Facilities

Access to advanced animal vivariums, specialized equipment for microbiome analysis (e.g., next-generation sequencing platforms, GC-MS), and comprehensive histology and immunology labs.

Customizable Study Designs

We don't offer one-size-fits-all solutions. Our services are tailored to your unique product and research questions.

Comprehensive Data Generation

We provide a holistic view of probiotic efficacy, combining clinical, histological, immunological, and microbiological endpoints.

Rigorous Quality Control

Strict adherence to robust quality assurance procedures ensures reliable and reproducible results.

Translational Focus

Our models are designed to be highly translatable to human conditions, providing valuable insights for clinical development.

Confidentiality & IP Protection

We operate under strict confidentiality agreements to protect your intellectual property.

Fig.3 Advanced technical platforms are used for probiotic efficacy evaluation. (Creative Biolabs Authorized)

Applications

  • New Probiotic Strain Development: Evaluating novel strains or consortia for their therapeutic effects.
  • Formulation Optimization: Testing different probiotic formulations (e.g., encapsulated vs. unencapsulated) for enhanced delivery and efficacy.
  • Mechanism of Action Studies: Elucidating the precise biological pathways through which probiotics exert their benefits.
  • Dose-Finding Studies: Determining optimal effective doses for future human trials.
  • Safety and Tolerability Assessments: Identifying any potential adverse effects in disease conditions.
  • Synergy Studies: Evaluating the combined effects of probiotics with prebiotics (synbiotics) or other therapeutic agents.
  • Regulatory Submission Support: Generating robust preclinical data to support IND applications and other regulatory filings.

Understanding the Mechanism of Action: How Probiotics Exert Their Influence

The probiotics' mechanisms of action in GI disorders are multifaceted and often strain-specific, including:

  • Competitive Exclusion of Pathogens: Probiotics can compete with harmful bacteria for adhesion sites on the intestinal mucosa and essential nutrients, thereby inhibiting pathogen colonization and growth.
  • Enhancement of Intestinal Barrier Integrity: Probiotics can strengthen the gut barrier by increasing mucus production and enhancing the expression of tight junction proteins, which prevent the translocation of toxins and pathogens into the bloodstream.
  • Immunomodulation: Probiotics can modulate both innate and adaptive immune responses within the gut, leading to the reduction of pro-inflammatory cytokines and the induction of regulatory mechanisms, thus attenuating inflammation.
  • Production of Antimicrobial Compounds: Many probiotic strains produce antimicrobial substances such as short-chain fatty acids (SCFAs), organic acids, hydrogen peroxide, and bacteriocins, which directly inhibit the growth of pathogenic bacteria.
  • Metabolic Modulation: Probiotics can influence host metabolism by fermenting undigested dietary fibers to produce beneficial SCFAs (e.g., butyrate, propionate, acetate), which serve as energy sources for colonocytes and possess anti-inflammatory properties.
  • Neurotransmitter Synthesis: Emerging research suggests some probiotics can influence the gut-brain axis by producing neurotransmitters or their precursors, impacting mood, behavior, and gut motility.

FAQs

What animal species do you primarily use for GI disorder models?

We primarily utilize rodent models (mice and rats) due to their well-characterized genetics, ease of manipulation, and cost-effectiveness. For specific projects requiring larger animal physiology, we can discuss collaborations for models such as pigs, which share significant GI similarities with humans.

Can you help with the regulatory aspects of my probiotic development?

While we do not provide direct regulatory consulting, the high-quality, reproducible data generated from our studies are designed to meet preclinical research standards and can significantly support your regulatory submissions.

What level of detail can I expect in the final report?

Our final reports are comprehensive, including detailed methodology, raw data, statistical analysis, clear graphical representations of results, and scientific interpretation of the findings. We aim for full transparency and actionable insights.

Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us
Solutions

Copyright © 2025 Creative Biolabs. All Rights Reserved.

Inquiry Basket